| Financial Year |
March 31 2023 |
| Monetary Funds |
395,973,342.55 |
| Held-for-trading Financial Assets |
29,000,000.00 |
| Notes Receivable |
45,417,340.41 |
| Accounts Receivable |
70,583,643.46 |
| Advances to Suppliers |
28,844,155.85 |
| Other Receivables |
3,593,108.21 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
127,772,900.97 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,780,981.81 |
| Total Current Assets |
733,981,545.20 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
108,695,437.95 |
| Under-construction Projects |
29,539,163.72 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
32,758,667.10 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
7,048,145.30 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
180,779,132.67 |
| Total Assets |
914,760,677.87 |
| Short-Term Loans |
10,020,935.33 |
| Trading Financial liabilities |
-- |
| Notes Payable |
66,000,000.00 |
| Accounts Payable |
37,804,423.45 |
| Accounts Received In Advance |
67,516.28 |
| Employee Compensation Payable |
6,858,307.11 |
| Taxes Payable |
8,390,928.18 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,717,077.23 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
241,571.04 |
| Other Current Liabilities |
6,596,480.57 |
| Sub-Total of Current Liabilities |
245,816,136.12 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,839,720.74 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
14,930,910.76 |
| Total Liabilities |
260,747,046.88 |
| Paid-In Capital(Or Share Stock) |
150,000,000.00 |
| Capital Surplus |
183,500,893.26 |
| Surplus Reserve |
44,311,751.32 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
264,847,962.44 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
654,013,630.99 |
| Owner's Equity（Stockholder's Equity） |
654,013,630.99 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
914,760,677.87 |
